Exceptional Ventures is an early-stage Venture Capital firm based in London that invests in high-impact businesses focused on helping people live happier, healthier, and longer lives, while championing a sustainable planet.
AlbionVC led the £18.3m Series A round, which will fund expansion across new treatment areas and clinical capabilities.
"Patients now expect the same convenience from healthcare that they get from banking or shopping—instant, mobile, on their terms. The technology exists to deliver this for minor conditions, but our system is still stuck requiring appointments, phone calls, physical visits – with no capacity for smart aftercare. We want to solve this, and scale the infrastructure that matches how people actually want to access care in 2026."
— Oskar Wenbar, Chief Medical Officer and co-founder
The financing round was led by Cornerstone with backing from several early stage investors.
"Rising care costs, an overstretched social care system, and the demands of daily life can leave families feeling guilty and stretched thin as they think about their elderly loved ones. That’s why I’m thrilled to back George and Alex as they build Gladys, a managed social care platform that makes it easy to find and book trusted caregivers and companions. Their mission is close to my heart: giving families peace of mind and helping everyone grow old with dignity, in the home they cherish, for as long as possible."
Explorer Investments led the seed round to support product development and international growth.
"We are thrilled to announce the successful closing of our funding round. This investment will enable us to further develop our AI-powered insurance validation platform and empower contractors and recruitment companies to achieve seamless insurance compliance and to get their global suppliers and contractors covered instantly. Jove is at the forefront of changing the landscape of how insurance is being quoted and purchased globally. This has never been done before."
Exceptional Ventures led the pre-seed round, with participation from Bethnal Green Ventures and Angel Academe.
"We are thrilled to partner with Rebecca and Alec on PreActiv’s journey to revolutionise the prehabilitation space. Their scalable, evidence-based programmes significantly reduce surgical complications and accelerate recovery, offering a cost-effective solution to the £14 billion burden on the NHS. PreActiv’s integration of patient data, support networks, and educational resources makes it a promising innovation in improving surgical outcomes and long-term health."
Morgan Stanley led the seed round to support platform expansion and data science development.
"Despite 90% of the UK’s 33.8 million female population experiencing monthly hormonal symptoms, women’s health has for too long been fragmented and underserved. Unfabled has already empowered thousands of women to find effective treatments for common, yet hugely disruptive, hormonal and reproductive conditions like PMS, Polycystic Ovary Syndrome (PCOS), endometriosis and menopause."
The funding round was led by Moneta Venture Capital with participation from new and existing backers.
"We’re proud that Rest Less has become an essential and trusted resource for today’s digitally native midlifers. With a one million strong community, one in seventeen of all 50 to 70 year olds in the UK is now a Rest Less member."
The funding round was led by ETF Partners with participation from new and existing investors to support platform expansion.
"In the race to achieve climate and other sustainable goals, the sophistication of sustainable and impact investing is rapidly advancing. Investors are demanding the facts on the social and environmental performance of their funds, just like they do financial return. We are proud to arm investors with trusted and transparent data, and we are honoured to power the most sophisticated investors in the world."
